References
- WHO. (2021). Weekly epidemiological update 13 Jul 2021. Retrieved 13.Jul.2021 from https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—13-july-202
- BBC. (2021). Covid-19 in the UK: how many coronavirus cases are there in your area? Retrieved 7.Jan.2021 from https://www.bbc.com/news/uk-51768274
- WHO. (2021). Draft landscape of COVID-19 candidate vaccines. Retrieved 7.Jan.2021 from https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- WHO. (2021). Weekly epidemiological update 12 Jan 2021. Retrieved 23.Jan.2021 from https://www.who.int/publications/m/item/weekly-epidemiological-update—12-january-202
- Baraniuk C. Covid-19: how the UK vaccine rollout delivered success, so far. BMJ. Retrieved 18.2021.
- Statistics OFN (2021). Coronavirus (COVID-19) latest insights: infections Retrieved 21.Jul.2021 from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections#infections-by-age
- Gov.UK. (2021). Coronavirus (COVID-19) cases in the UK. Retrieved 28.Jul.2021 from https://coronavirus.data.gov.uk/
- Statistics OFN (2021). Coronavirus (COVID-19) latest insights: vaccines. Retrieved 28.Jul.2021 from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/vaccines
- Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020;27(2):225–228. DOI:10.1038/s41591-020-1124-9
- Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50. DOI:10.1016/j.bbi.2021.03.008
- Palamenghi L, Barello S, Boccia S, et al. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol. 2020;35(8):785–788. DOI:10.1007/s10654-020-00675-8
- Chou WYS, Budenz A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020;35(14):1718–1722. DOI:10.1080/10410236.2020.1838096.
- Sniehotta FF, Scholz U, Schwarzer R. Bridging the intention–behaviour gap: planning, self-efficacy, and action control in the adoption and maintenance of physical exercise. Psychology & Health. 2005;20(2):143–160. DOI:10.1080/08870440512331317670.
- van Overbeeke E, Whichello C, Janssens R, et al. Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discov Today. 2019;24(1):57–68. DOI:10.1016/j.drudis.2018.09.015
- González-Lorenzo M, Piatti A, Coppola L, et al. Conceptual frameworks and key dimensions to support coverage decisions for vaccines. Vaccine. 2015;33(9):1206–1217. DOI:10.1016/j.vaccine.2014.12.020
- Guo N, Wang J, Nicholas S, et al. Behavioral differences in the preference for hepatitis B virus vaccination: a discrete choice experiment. Vaccines (Basel). 2020;8(3):527. DOI:10.3390/vaccines8030527
- Determann D, Korfage IJ, Lambooij MS, et al. Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment. PLoS ONE. 2014;9(7):e102505. DOI:10.1371/journal.pone.0102505
- Clark MD, Determann D, Petrou S, et al. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32(9):883–902. DOI:10.1007/s40273-014-0170-x
- de Bekker-Grob EW, Donkers B, Bliemer MCJ, et al. Can healthcare choice be predicted using stated preference data? Soc Sci Med. 2020;246:112736. DOI:10.1016/j.socscimed.2019.112736
- Borriello A, Master D, Pellegrini A, et al. Preferences for a COVID-19 vaccine in Australia. Vaccine. 2021;39(3):473–479. DOI:10.1016/j.vaccine.2020.12.032
- Craig BM. United States COVID-19 vaccination preferences (CVP): 2020 hindsight. Patient-Patient-Centered Outcomes Res. 2021;14(3):309–318. DOI:10.1007/s40271-021-00508-0.
- Leng A, Maitland E, Wang S, et al. Individual preferences for COVID-19 vaccination in China. Vaccine. 2021;39(2):247–254. DOI:10.1016/j.vaccine.2020.12.009
- McPhedran R, Toombs B. Efficacy or delivery? An online discrete choice experiment to explore preferences for COVID-19 vaccines in the UK. Econ Lett. 2021;200:109747.
- Schwarzinger M, Watson V, Arwidson P, et al. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–21. DOI:10.1016/S2468-2667(21)00012-8
- Dong D, Xu RH, Yi WE, et al. Public preference for COVID-19 vaccines in China: a discrete choice experiment. Health Expectations. 2020;23(6):1543–1578. DOI:10.1111/hex.13140
- Bridges JFP, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2021;14(4):403–413. DOI:10.1016/j.jval.2010.11.013.
- Hauber AB, González JM, Groothuis-Oudshoorn CGM, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315. DOI:10.1016/j.jval.2016.04.004.
- Determann D, Korfage IJ, Fagerlin A, et al. Public preferences for vaccination programmes during pandemics caused by pathogens transmitted through respiratory droplets–a discrete choice experiment in four European countries, 2013. Eurosurveillance. 2016;21(22):30247. DOI:10.2807/1560-7917.ES.2016.21.22.30247
- Coast J, Al‐Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–741. DOI:10.1002/hec.1739
- Trapero-Bertran M, Rodríguez-Martín B, López-Bastida J, et al. What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review. PLoS ONE. 2019;14(7):e0219905. DOI:10.1371/journal.pone.0219905
- Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13. DOI:10.1016/j.jval.2012.08.2223
- Ryan M, Skåtun D. Modelling non‐demanders in choice experiments. Health Econ. 2004;13(4):397–402. DOI:10.1002/hec.821.
- Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. Madison, WI: Research Publishers LLC; 2010.
- Pearmain D, Kroes EP. Stated preference techniques: a guide to practice. 1990.
- Statistics OFN (2021). Coronavirus and vaccine hesitancy, Great Britain: 26 May to 20 June 2021. Retrieved 21.Jul.2021 from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/bulletins/coronavirusandvaccinehesitancygreatbritain/26mayto20june2021.
- Zhou M, Thayer WM, Bridges JF. Using latent class analysis to model preference heterogeneity in health: a systematic review. Pharmacoeconomics. 2018;36(2):175–187. DOI:10.1007/s40273-017-0575-4.